HWH International Receives Nasdaq Delisting Notice

HWH International Inc. (HWH) filed an 8-K with the SEC on May 29, 2026, reporting receipt of a notice of delisting from Nasdaq under Item 3.01.

The filing states that Nasdaq has informed the company it does not satisfy a listing rule required for continued listing on the Nasdaq Capital Market. Per the SEC document, the notice identifies the specific rule violated and grants the company a cure period to regain compliance before further action is taken.

The company now operates without confirmed continued listing on the Nasdaq Capital Market. Prior to the notice, HWH shares traded on the exchange subject to ongoing compliance with all applicable listing standards. The new state requires HWH to address the deficiency within the cure period outlined in the notice or face suspension and potential delisting.

The filing triggers an obligation for the company to monitor the cure timeline and, if necessary, submit a plan or take remedial steps by the deadline set by Nasdaq.

Downstream, the company must either cure the deficiency or appeal within the exchange's procedural deadlines. Failure to regain compliance by the end of the cure period will require Nasdaq to issue a delisting determination, after which HWH shares would trade over-the-counter if no extension or hearing reverses the decision.

The company is also required to disclose any material updates on its compliance status in subsequent SEC filings. Standard exchange rules provide a typical 180-day cure window for many deficiencies, though the exact period is defined in the notice itself.

This marks the first public disclosure by HWH International of a Nasdaq delisting notice since its original listing. The Form 8-K constitutes the official record of the exchange's determination and the company's notification obligations under SEC rules.